Fibrosis inhibitor for implanted organ

Details Fibrosis inhibitor for implanted organ Fibrosis inhibitor for implanted organ

2010-01-28

2011-12-13

Allen, Marianne P (Department: 1647)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

08076289

ABSTRACT:
A pharmaceutical preparation comprising a hepatocyte growth factor or a DNA molecule encoding the same and the like according to the present invention can suppress the fibrosis of a transplanted organ after organ transplantation. The present invention is useful in the fields of organ transplantation and regeneration therapy.

REFERENCES:
patent: 5776464 (1998-07-01), Nakamura et al.
patent: 6099841 (2000-08-01), Hilian et al.
patent: 6699837 (2004-03-01), Nakamura et al.
patent: 7563768 (2009-07-01), Nakamura et al.
patent: 1 036 566 (2000-09-01), None
patent: 7-258111 (1995-10-01), None
patent: 7-300426 (1995-11-01), None
patent: 10-194986 (1998-07-01), None
patent: 2000-239182 (2000-09-01), None
patent: 96/40914 (1996-12-01), None
patent: 01/26694 (2001-04-01), None
patent: 02/05840 (2002-01-01), None
H. Tashiro et al., “Hepatocyte Growth Factor Prevents Chronic Allograft Dysfunction in Liver-Transplanted Rats”,Transplantation, vol. 76, No. 5, pp. 761-765, Sep. 15, 2003.
K. Yamaura et al., “Suppression of Acute and Chronic Rejection by Hepatocyte Growth Factor in a Murine Model of Cardiac Transplantation”,Circulation, vol. 110, No. 12, pp. 1650-1657, published on the internet on Sep. 13, 2004 at http://circ.ahajournals.org/.
K. Yamaura et al., “Suppression of Acute and Chronic Rejection by Hepatocyte Growth Factor in a Murine Model of Cardiac Transplantation”,Circulation, vol. 110, No. 12, pp. 1650-1657, Sep. 21, 2004.
Y. Isaka et al., “Electroporation-mediated HGF gene transfection protected the kidney against graft injury”,Gene Therapy(2005), vol. 12, No. 10, pp. 815-820.
I. Herrero-Fresneda et al., “HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms”,Kidney International Society of Nephrology(2006), vol. 70, No. 2, pp. 265-274.
S. Mizuno et al., “Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease”,The Journal of Clinical Investigation(1998), vol. 101, No. 9, pp. 1827-1834.
K. Yazawa et al., “Direct transfer of hepatocyte growth factor gene into kidney suppresses cyclosporine A nephrotoxicity in rats”,Nephrology Dialysis Transplantation(2004), vol. 19, No. 4, pp. 812-816.

Affiliated with

Also associated with

Rating

Fibrosis inhibitor for implanted organ does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fibrosis inhibitor for implanted organ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrosis inhibitor for implanted organ will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4309520